Advertisement

Topics

Chronic Kidney DiseaseMineral Bone Disorders CKDMBD: Competitive Landscape to 2027 [Report Updated: 14032019] Prices from USD $3495

08:30 EDT 14 Jun 2019 | BioPortfolio Reports

Chronic Kidney DiseaseMineral Bone Disorders CKDMBD: Competitive Landscape to 2027


Summary


Chronic Kidney DiseaseMineral Bone Disorders CKDMBD is one of the many complications associated with overall CKD. The systemic disorder is identified from high parathyroid hormone and disrupted K+/Ca2+ levels caused by a decreasing glomerular filtration rate GFR due to renal impairment.


This report provides an assessment of the pipeline, clinical, and commercial landscape of CKDMBD. Overall, GlobalData expects minimal changes to overall disease treatment, with exceptions being the launch of the novel NHE3 and novel CASR in the US and Japan markets respectively.


Scope


Pipeline Assessment: regional breakdown, promising latestage products, earlystage pipeline by molecule type

Clinical Trials Assessment: trial breakdown by phase, leading industry and nonindustry sponsors, enrollment analytics

Commercial Assessment: leading marketed products, current and future players

Competitive Landscape Analysis: key market events 20172027.


Reasons to buy


Develop and design your inlicensing and outlicensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global CKDMBD market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global CKDMBD market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Original Article: Chronic Kidney DiseaseMineral Bone Disorders CKDMBD: Competitive Landscape to 2027 [Report Updated: 14032019] Prices from USD $3495

NEXT ARTICLE

More From BioPortfolio on "Chronic Kidney DiseaseMineral Bone Disorders CKDMBD: Competitive Landscape to 2027 [Report Updated: 14032019] Prices from USD $3495"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Endocrinology
Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...